Showing 331-340 of 2331 results for "".
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Advances in Neuromodulation for Essential Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/advances-in-neuromodulation-for-essential-tremor/32163/Advancements in neuromodulation continue to expand treatment options for medication-refractory essential tremor.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Managing Symptoms of Anxiety, Panic, Depression, Apathy, and Pseudobulbar Effect in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/managing-symptoms-of-anxiety-panic-depression-apathy-and-pseudobulbar-effect-in-individuals-with-parkinson-disease/37655/Neuropsychiatric symptoms associated with Parkinson disease, including anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment as well as consideration of various treatment options to improve quality of life in this population.Moyamoya: An Update for the Practicing Neurologist
https://practicalneurology.com/diseases-diagnoses/stroke/moyamoya-an-update-for-the-practicing-neurologist/30306/Distinguishing between definite MMD, probable MMD, and MMS may not have significant practical implications.Migraine: Essentials of Patient Evaluation and Acute Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0209_01-php/30944/Clinicians who are knowledgeable of acute treatments, able to combine treatment modalities, and skilled at understanding patients' needs can successfully individualize treatment.Expert Opinion Cauda Equina Syndrome: A Case Report and Review of the Literature
https://practicalneurology.com/columns/practice-management/expert-opinion-cauda-equina-syndrome-a-case-report-and-review-of-the-literature/30700/The Role of Abuse Deterrent Formulations of Opioids in Pain Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-role-of-abuse-deterrent-formulations-of-opioids-in-pain-management/30408/An emerging class of potentially safer opioid medications will offer new challenges and opportunities for both patients and physicians.New and Emerging Therapies in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/new-and-emerging-therapies-in-parkinsons-disease/30473/As the therapeutic landscape expands, an increasing range of options and a promising horizon will improve management of motor fluctuations for many patients with Parkinson's disease.